18 and older, any sex, with Tobacco Use, Cigarette Use. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Very Low Nicotine Content (VLNC) MisperceptionPrimary· During one day survey
Measured by a 3 item scale. Very low nicotine content (VLNC) Misperception measured with 3 questions, the final VLNC misperception score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more harmful than other cigarettes, and 5 indicates a perception that VLNC are much less harmful than other cigarettes, and 3 is a perception that VLNC are as harmful as other cigarettes.
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
3.12
± 0.56
Continued-harm-framed Messages About the Harm of VLNC
3.04
± 0.61
Myth-refuting Messages About the Harm of VLNC
3.04
± 0.54
Control Messages About Littering
3.36
± 0.80
Quit IntentionsSecondary· During one day survey
Measured by a 3 item scale. Quit intention measured with 3 questions, the final quit intention score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low intention to quit smoking, and 5 indicates a high intention to quit.
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
2.88
± 1.22
Continued-harm-framed Messages About the Harm of VLNC
2.80
± 1.13
Myth-refuting Messages About the Harm of VLNC
2.87
± 1.27
Control Messages About Littering
2.85
± 1.26
Perceived Message EffectivenessSecondary· During one day survey
Measured by a 3 item scale after each message, 9 items total. Perceived message effectiveness measured with 3 questions per message. The final perceived message effectiveness score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low perceived message effectiveness, and 5 indicates high perceived message effectiveness.
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
3.07
± 0.87
Continued-harm-framed Messages About the Harm of VLNC
3.26
± 0.86
Myth-refuting Messages About the Harm of VLNC
3.17
± 0.90
Control Messages About Littering
2.45
± 0.96
Perceived UnderstandabilitySecondary· During one day survey
Perceived Understandability is measured with 1 question on a scale of 1 to 5: "How easy was it to understand the three black and white messages we showed you earlier?", where 1 = "Not at all", 5 = "Very", and 3 = "Somewhat"
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
4.48
± 0.82
Continued-harm-framed Messages About the Harm of VLNC
4.5
± 0.83
Myth-refuting Messages About the Harm of VLNC
4.37
± 0.86
Control Messages About Littering
4.35
± 0.94
AttentionSecondary· During one day survey
Attention is measured with 1 question on a scale of 1 to 5: "How much did the messages grab your attention?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
3.26
± 1.22
Continued-harm-framed Messages About the Harm of VLNC
2.14
± 1.10
Myth-refuting Messages About the Harm of VLNC
3.13
± 1.16
Control Messages About Littering
2.73
± 1.12
Negative AffectSecondary· During one day survey
Negative affect is measured with 1 question on a scale of 1 to 5: "How much did the messages make you feel scared?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
2.18
± 1.31
Continued-harm-framed Messages About the Harm of VLNC
1.97
± 1.15
Myth-refuting Messages About the Harm of VLNC
1.93
± 1.13
Control Messages About Littering
1.42
± 0.78
Cognitive ReactionsSecondary· During one day survey
Cognitive Reactions are measured with 1 question on a scale of 1 to 5: "How much did the messages make you think about the risk of smoking cigarettes that have 95% less nicotine?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
2.68
± 1.29
Continued-harm-framed Messages About the Harm of VLNC
2.68
± 1.28
Myth-refuting Messages About the Harm of VLNC
2.66
± 1.23
Control Messages About Littering
1.97
± 1.11
Social InteractionsSecondary· During one day survey
Social Interactions are measured with 1 question on a scale of 1 to 5: "How much would you talk with other people about the messages?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
2.28
± 1.28
Continued-harm-framed Messages About the Harm of VLNC
2.16
± 1.16
Myth-refuting Messages About the Harm of VLNC
2.24
± 1.17
Control Messages About Littering
2.09
± 1.17
ReactanceSecondary· During one day survey
Reactance is measured with 1 question on a scale of 1 to 5: "How much do you feel that the messages are trying to manipulate you?", where 1 = "Not at all", 5 = "Very much", and 3 = "Somewhat"
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
2.81
± 1.41
Continued-harm-framed Messages About the Harm of VLNC
2.61
± 1.40
Myth-refuting Messages About the Harm of VLNC
2.62
± 1.36
Control Messages About Littering
2.44
± 1.33
Interest in Other Nicotine ProductsSecondary· During one day survey
Measured by a 3 item scale. Interest in other nicotine products with 3 questions, the final score is a mean of the response to the 3 questions, on a scale of 1 to 5, where 1 indicates low interest in other nicotine products, and 5 indicates a high interest in other nicotine products.
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
2.75
± 0.86
Continued-harm-framed Messages About the Harm of VLNC
2.80
± 0.78
Myth-refuting Messages About the Harm of VLNC
2.77
± 0.85
Control Messages About Littering
2.66
± 0.84
Percentage of Participants With Very Low Nicotine Content (VLNC) Misperception About Harm (Dichotomized)Primary· During one day survey
Very low nicotine content (VLNC) Misperception of Harm was measured with 1 question, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more harmful than other cigarettes, and 5 indicates a perception that VLNC are much less harmful than other cigarettes, and 3 is a perception that VLNC are as harmful as other cigarettes. The results were dichotomized to indicate the percentage of people who hold the misperception. Specifically, responses of "much less likely" (5) or "less likely" (4) were recoded as 1 (having the misperception), and responses of "Much more likely" (1), "M
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
18.3
13.6 – 23.0
Continued-harm-framed Messages About the Harm of VLNC
12.6
8.6 – 16.7
Myth-refuting Messages About the Harm of VLNC
11.4
7.5 – 15.3
Control Messages About Littering
38.2
32.3 – 44.1
Percentage of Participants With Very Low Nicotine Content (VLNC) Misperception About Cancer (Dichotomized)Primary· During one day survey
Very low nicotine content (VLNC) Misperception of Risk of Cancer was measured with 1 question, on a scale of 1 to 5, where 1 indicates a perception that VLNC are much more likely to cause cancer than other cigarettes, and 5 indicates a perception that VLNC are much less likely to cause cancer than other cigarettes, and 3 is a perception that VLNC are as likely to cause cancer as other cigarettes. The results were dichotomized to indicate the percentage of people who hold the misperception. Specifically, responses of "much less likely" (5) or "less likely" (4) were recoded as 1 (having the misp
Group
Value
95% CI
Emotion-based Messages About the Harm of VLNC
16.8
12.2 – 21.4
Continued-harm-framed Messages About the Harm of VLNC
11.1
7.3 – 14.9
Myth-refuting Messages About the Harm of VLNC
9.5
5.9 – 13.1
Control Messages About Littering
31.8
26.2 – 37.5
Sponsor's own description
Tobacco use is the leading preventable cause of cancer and cancer deaths in the US. While most (69%) smokers want to quit, only 6% succeed in doing so each year. For many smokers, the addictiveness of nicotine makes quitting very difficult. To reduce cigarette smoking and resulting harms, FDA has announced a comprehensive approach to tobacco and nicotine regulation that includes moving toward a very low nicotine content (VLNC) standard for cigarettes. Greatly reduced nicotine levels would facilitate smoking cessation. However, the maximal success of the policy may require public understanding that, although these new cigarettes are less addictive, their high toxicity and carcinogenicity are unchanged. Yet, nearly half of adult smokers incorrectly think smoking VLNC cigarettes is less harmful than smoking current cigarettes (the VLNC misperception). Additionally, 24% of smokers said they would be less likely to quit if a VLNC regulation is enacted. Thus, the VLNC misperception may partially undermine a nicotine reduction policy. Although communication research suggests it is challenging to change people's incorrect understanding, new communication techniques may help reduce the VLNC misperception. In this randomized trial we will examine whether messages about the harm of VLNC cigarettes can reduce the VLNC misperception and increase intention to quit in a nicotine reduction scenario.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other UNC Lineberger Comprehensive Cancer Center trials
Trials by the same sponsor.
NCT06656936 — The PharmFIT Study
· NA
· not yet recruiting
NCT05937659 — Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT
· not yet recruiting
NCT07479199 — Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
· not yet recruiting
NCT07069595 — PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
· Phase 2
· recruiting
NCT04266730 — Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab
· Phase 1
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by UNC Lineberger Comprehensive Cancer Center
Last refreshed: 8 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04974489.